05 January 2026 - Daily Current Affairs Updates

GS–1 | MODERN INDIAN HISTORY

1. Rani Velu Nachiyar

Subtopic: Early Anti-Colonial Resistance & Women Leadership

Value Addition:

• Historical Identity: Rani Velu Nachiyar (born 1730) was the queen of Sivaganga, Tamil Nadu, and among the earliest Indian rulers to resist British colonial expansion.

• Early Life: Born as the princess of Ramnad (Ramanathapuram); received royal education.

• Military Training:

  • Skilled in horse riding, archery, warfare.

  • Trained in traditional martial arts like Silambam and Valari.

• Strategic Alliances:

  • Formed a crucial alliance with Hyder Ali of Mysore, gaining military and logistical support.

• Women’s Military Unit:

  • Established the Udaiyaal Battalion, regarded as one of the earliest all-women military units in world history.

• Innovative Warfare:

  • Her commander Kuyili carried out what is considered the first recorded suicide attack in Indian history by destroying a British ammunition depot (1780).

• Military Achievement:

  • Successfully recaptured Sivaganga from the British in 1780, nearly 77 years before the Revolt of 1857.

• Contemporary Recognition:

  • PM paid homage on her birth anniversary, reaffirming her place in India’s freedom narrative.

Subject Analysis:

• Expands the timeline of India’s freedom struggle to the 18th century.

• Highlights women’s leadership and indigenous military strategy in anti-colonial resistance.

• High-value GS-1 example for early resistance movements and regional history.

GS–2 | ECONOMY & TRADE POLICY

2. Credit-Linked Sub-Schemes under Export Promotion Mission

Subtopic: Export Finance, MSMEs & Trade Facilitation

Value Addition:

A. Interest Subvention for Export Credit

• Nature: Rupee-denominated pre- and post-shipment export credit.

• Base Support:

  • 2.75% interest subvention for eligible exporters.

• Market-Linked Incentive:

  • Additional interest benefit for exports to under-represented or emerging markets.

• Financial Cap:

  • Maximum benefit of ₹50 lakh per exporter for FY 2025–26.

• Eligibility:

  • Limited to exports under a notified positive list of HS 6-digit tariff lines.

  • Covers ~75% of India’s tariff lines.

B. Collateral Support for Export Credit

• Implementing Partner: Credit Guarantee Fund Trust for Micro and Small Enterprises (CGTMSE).

• Guarantee Coverage:

  • Up to 85% for micro & small exporters.

  • Up to 65% for medium exporters.

• Exposure Limit:

  • Maximum guaranteed exposure of ₹10 crore per exporter per year.

• Eligibility:

  • Same positive-list-based criteria as interest subvention scheme.

Export Promotion Mission (Overall Framework)

• Launch: November 2025.

• Duration: FY 2025–26 to FY 2030–31 (6 years).

• Total Outlay: ₹25,060 crore.

• Core Objective: Affordable and accessible trade finance, with focus on MSMEs and labour-intensive sectors (e.g., textiles).

Mission Architecture:

• Niryat Protsahan: Financial support (interest subvention, collateral guarantees, e-commerce export credit cards).

• Niryat Disha: Non-financial support (quality standards, branding, regulatory compliance, logistics).

Subject Analysis:

• Strengthens India’s export competitiveness and MSME participation in global trade.

• Addresses both credit constraints and structural bottlenecks.

• High-probability GS-2 topic on trade policy instruments and export promotion.

GS–2 | HEALTH GOVERNANCE / INTERNATIONAL ORGANISATIONS

3. WHO Pharmacovigilance Contributions (India’s Rise)

Subtopic: Drug Safety, Global Health Governance

Value Addition:

• Achievement: India rose from 123rd to 8th position globally in WHO pharmacovigilance contributions.

• Pharmacovigilance Programme of India (PvPI):

  • Launched in 2010.

  • India’s flagship programme for monitoring adverse drug reactions (ADRs).

• Core Function:

  • Collects, analyses, and transmits ADR data to CDSCO for regulatory action.

• WHO Programme for International Drug Monitoring:

  • Established in 1968.

  • Focuses on global medicine and vaccine safety.

• Global Database:

  • VigiBase serves as WHO’s global repository of adverse event reports.

Subject Analysis:

• Demonstrates India’s growing role in global health surveillance systems.

• Relevant for GS-2 questions on WHO mechanisms and public health governance.

GS–3 | ENERGY & ENVIRONMENT GOVERNANCE

4. Battery Pack Aadhaar System

Subtopic: EV Ecosystem, Circular Economy & Digital Regulation

Value Addition:

• Policy Status: Draft guidelines released by the Central Government.

• Definition:

  • A digital identification and data-tracking system for batteries across their lifecycle.

• Core Objective:

  • Enhance traceability, transparency, sustainability, and environmental accountability.

• Unique Identification:

  • Each battery assigned a 21-character Battery Pack Aadhaar Number (BPAN) with QR code.

• Coverage:

  • All EV battery packs.

  • Industrial batteries with capacity above 2 kWh.

• Legal Responsibility:

  • Battery producers/importers must assign BPAN, including for self-consumed batteries.

• Static Data Stored:

  • Manufacturer details, battery specs, material composition, carbon footprint.

• Dynamic Data Stored:

  • Battery health, charge-discharge cycles, thermal events, end-of-life status.

• System-Level Significance:

  • Enables second-life usage, regulatory compliance, and efficient recycling.

Subject Analysis:

• Supports India’s transition to a circular battery economy.

• Key GS-3 example linking EV growth, digital governance, and environmental regulation.

GS–3 | BIODIVERSITY & CONSERVATION

5. Galaxy Frog (Melanobatrachus indicus)

Subtopic: Endemic Species, Ecotourism & Habitat Stress

Value Addition:

• Taxonomic Status:

  • Only known species of its genus; taxonomically unique.

• Geographic Distribution:

  • Endemic to the Western Ghats of south-western India.

• Habitat:

  • High-altitude evergreen and shola forest ecosystems.

• Morphology:

  • Rare, slender frog with nearly uniform body width.

• Ecology:

  • Terrestrial; associated with leaf litter and moist ground cover.

• Conservation Status:

  • Vulnerable (IUCN Red List).

• Recent Concern:

  • Local population decline linked to unregulated photo tourism.

Subject Analysis:

• Highlights conservation challenges from tourism pressure in biodiversity hotspots.

• Important GS-3 case for endemic species protection and Western Ghats ecology.

GS–3 | BIODIVERSITY / AVIFAUNA

6. Sirkeer Malkoha (Taccocua leschenaultii)

Subtopic: Bird Diversity, Range Extension & Behaviour

Value Addition:

• News Context: First recorded sighting in Uttarkashi (Uttarakhand).

• Taxonomy: A distinct species of cuckoo.

• Reproductive Behaviour:

  • Does not practise brood parasitism; builds its own nest.

• Distribution:

  • Sub-Himalayan regions of India, Bangladesh, Sri Lanka; scattered in Pakistan and Rajasthan.

• Habitat:

  • Scrublands, open forests, hilly terrain below 1,500 m altitude.

• Physical Features:

  • Length: 42–44 cm; long tail.

  • Olive-brown upperparts, lighter underparts.

  • Curved red bill with yellow tip; grey legs.

• Behaviour:

  • Sexes identical; quiet and elusive.

• Adaptation:

  • Zygodactyl feet aiding ground movement and branch gripping.

• Diet:

  • Insects, small lizards, berries, seeds.

• IUCN Status: Least Concern.

Subject Analysis:

• Useful for prelims on bird behaviour and distribution shifts.

• Reflects ecological adaptability and range variation.

GS–3 | SCIENCE & TECHNOLOGY

7. PathGennie

Subtopic: Computational Biology & Drug Discovery

Value Addition:

• Developed by: Scientists under the Ministry of Science & Technology.

• Nature: Open-source computational framework.

• Core Purpose:

  • Accelerates simulation of rare molecular events, especially drug–protein unbinding.

• Scientific Challenge Addressed:

  • Accurate modelling of ligand unbinding, crucial for drug residence time.

• Conceptual Approach:

  • Mimics a natural selection–like process instead of force-based bias.

• Key Features:

  • Captures rare events without artificial acceleration.

  • Generates multiple competing unbinding pathways.

  • Reduces bias common in conventional simulations.

• Applications:

  • Faster drug discovery.

  • Chemical reactions, catalysis, phase transitions, self-assembly.

• Tech Compatibility:

  • Integrates with machine-learning workflows.

Subject Analysis:

• High-value GS-3 topic linking AI, computational science, and pharmaceutical innovation.

• Demonstrates India’s capability in advanced scientific software development.